Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens
NCT03298945Phase 4Completed
- Sponsor
- VA Office of Research & Development
- Start
- Dec 2018
- Primary completion
- Dec 2023
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
A Phase 4 trial of polyethylene glycol 3350 in colorectal cancer (CRC), sponsored by VA Office of Research & Development. Started Dec 2018; status: completed.
02
Drugs
polyethylene glycol 3350
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03298945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03298945.